New Ideas.
Better Results.

Blue Matter is a consulting firm serving the life sciences industry. We strive to bring a new approach to consulting with original ideas that deliver a meaningful impact.

Contact Us

Our Purpose

We are proud to be part of an industry that is pushing the boundaries of science and technology to improve people’s lives. Our role is to help our clients identify unique insights, generate new ideas and drive meaningful results to get the most out of their products, portfolios and teams.

We began our careers in established consulting firms where we developed valuable experience and industry knowledge. During this time, we came to see that rigid processes often interfered with original thinking and led to bloated deliverables packed with mediocre answers.

A group of us like-minded, passionate consultants believed there was a better approach and founded Blue Matter to provide a platform to foster innovation and creativity in consulting.

Our Difference

Industry and scientific knowledge, analysis and insights. Left brain thinking. This is the foundation of our discipline. Creativity and imagination. Constantly challenging conventional thinking and seeking fresh ideas. Right brain thinking. We’re passionate about this; it’s the reason our clients come back.

The key to winning is effective differentiation. And effective differentiation comes from originality–thinking that is grounded in reason and infused with imagination.

"The terrific work you did resulted in a substantial change to our commercial strategy."

- Chairman of the Board, Small Biotech

"Thank you very much for the great work and partnership. You are one of the rare breed of consultants whom I trust. You will always be on my speed dial if we need help with anything."

- Chief Commercial Officer, Small Biotech

"I appreciate all of the great work you have done for our team this past year and look forward to continued partnership in the New Year."

- Chief Commercial Officer, Mid-sized Diagnostic Company

"Your preparation and support has been instrumental in achieving our desired outcome."

- Franchise Commercial Lead, Global Biotech

"Thank you all so much for the extremely successful project...I couldn't be happier with the way that it went."

- Sr. Product Manager, Diagnostic Company

"This project was excellent, from the content development to facilitation. Many, many thanks for the great work!"

- Director of Marketing, Diagnostic Company

"The process was great, I loved that I didn't have to manage you that much. Everything was highly organized and done on time. Quality and originality of thinking was also good."

- Global Commercial Lead, Large Biotech

"Great project. I was learning as we went along; good expertise — brought in examples from other projects."

- Global Commercial Lead, Large Biotech

Our Clients

Our clients include: top global bio-pharmaceutical companies with large, diverse product portfolios to small emerging players with one asset in development, leading diagnostic companies, and investment houses. We work with CEOs, Chief Commercial Officers, Franchise Heads, Product Directors, Functional Area Leaders. 90%+ of our business is from repeat, satisfied customers.

Our Services

Shape Innovative Products

Drive Successful Launches

Build Great Portfolios and Companies

Pathfinder Capabilities

Blue Matter offers in-depth market expertise across North American and European markets.

Our Pathfinder offerings are specifically designed to help growing biopharma companies succeed in European markets.

Learn more: 7 Keys to Success in Europe

Want to Join Our Team?

Blue Matter offers enriching project experiences with a diverse range of strategic, client-facing projects in the exciting and innovative life sciences industry.

Join Our Team


If you're a Ph.D. thinking about a #ConsultingCareer, then check out the @PhDtoConsulting Conference on 25 Sept. Ou…

New White Paper: #RareDisease markets are complex ecosystems. A #biopharma company must determine its role in that…

They’re In! – The Results of Our Latest Values Survey

In an earlier article, we introduced readers to our quarterly Values Survey.  Our “People First” culture is incredibly important to all of our team members, and we work hard to maintain and continuously improve it.  That means staying true to our core values, which are based on a deep-seated desire to foster a happy, productive … Read More

Success in Rare Diseases, Part I: Understanding the Rare Disease Ecosystem

It’s a safe bet that anyone reading this article is familiar with the concept of an ecosystem. When we think of an ecosystem, we most often imagine how one exists in nature: a complex web of living organisms and non-living components (such as water, air, soil, rocks, and so on), all interacting with one another … Read More

A Happy Team: Direct Result of a “People First” Culture

If you’ve been following along in this series of articles on Blue Matter’s People First culture, then you probably know by now that building a happy and motivated team is super important to us.  In fact, it’s in our core values.  After all, taking every reasonable step to ensure a happy team is the right … Read More

Living Our “People First” Culture: The Blue Matter Values Survey

In a previous article, Emily Hua described our People First culture and why It’s so important to us.  Today, I want to add a little more to the story by telling you about our Values Survey. Lots of companies out there will talk about their values.  However, not many are willing to truly measure whether … Read More

Our Foundation: A “People First” Culture

If you’ve followed our blog for any length of time, you’ve probably noticed that we like to create high-value content on some of the leading topics in the biopharma industry.  Today, I want to shift gears and write a bit about Blue Matter as a company and its culture. We’re growing rapidly, always engaging with … Read More

Blue Matter “Breakfast Club” Meeting #5: Practical Implications of the COVID-19 Crisis for Biopharma

The Blue Matter Breakfast Club is an ongoing series of discussion forums (now virtual due to COVID-19), hosted by our team in Europe.  These forums are by invitation, bringing together leading executives from biopharma companies and other organizations to discuss critical business issues. The fifth Breakfast Club meeting took place on 8th July 2020.  The … Read More

T Cell-Based Therapies in Oncology: Landscape Evolution After a Turbulent 1H2020

Six months ago, we published an in-depth review of the cell-based immunotherapy landscape, including forward-facing declarations of 2020 data releases, filings, etc. that would address key outstanding questions, namely: Six months later, despite the unprecedented and unanticipated impact of COVID-19 on corporate operations, clinical trial functions, and regulatory body decision-making, there have been multiple key … Read More